Crescent Biopharma, Inc. (CBIO)

Last Closing Price: 12.91 (2026-11-19)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Crescent Biopharma, Inc. (CBIO) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$3.12M
$-37.73M
Cost of Goods Sold
--
$3.12M
$43.02M
$-39.91M
$2.18M
$-37.73M
$-37.73M
$-37.73M
$-37.73M
$-37.73M
$-37.73M
$-39.91M
$-39.84M
39.06M
39.06M
$-0.90
$-0.90
Balance Sheet Financials
$295.21M
$0.81M
$4.29M
$299.50M
$23.49M
--
$1.73M
$25.22M
$270.28M
$274.28M
$274.28M
38.18M
Cash Flow Statement Financials
$-55.34M
$-6.39M
$138.00M
$213.30M
$289.58M
$76.28M
$12.30M
--
--
Fundamental Metrics & Ratios
12.57
--
--
--
--
100.00%
-1280.30%
-1280.30%
--
-1210.33%
-1210.33%
$-53.73M
--
--
--
0.01
--
--
--
-13.96%
-13.75%
-12.60%
-13.75%
$7.18
$-1.38
$-1.42